FineBM Co., Ltd. (CEO Lee Sang-eok) announced that it will participate in the 3th International Medical Equipment & Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26 (Thu) to 38 (Sun).
FineBM was established for the localization of absorbable sutures for surgical operations using biocompatible biopolymer as a core raw material, and has since expanded its business area to the professional medical-based esthetic field and general consumer cosmetic field, marking its 11th anniversary this year. It is a medical device manufacturing company that was hit by a car.
With a thorough quality management system, we have obtained international quality certifications such as CE and ISO as well as certifications from the Ministry of Food and Drug Safety in Korea. Based on stable production systems, development capabilities, and active marketing, there is.
In this exhibition, we introduce Medical Aesthetic Thread, which is absorbed into the body. FineBM explained that the product is made of biocompatible biopolymers that have been proven safe and effective for many years in the market, and is hydrolyzed and absorbed and discharged in the human body. A company official said, “Surgical sutures that have been verified to have no toxic damage, can be safely used, and provide consistent absorption rate and excellent tensile strength, as well as a balanced contour and skin elasticity and volume improvement that can be used without an incision process. We plan to introduce products, etc.”
In addition, “Our company, established in 2011, specializes in manufacturing biodegradable medical sutures, and is conducting everything from R&D to production and marketing on its own. With the rapid qualitative and quantitative growth of the domestic and international cosmetic surgery field, the need for related products has increased. We have developed products to suit the new market.”
Currently, FineBM is supplying products to major general hospitals and clinics at home and abroad, and collaborating with medical staff through various conferences and papers. It is said that he is constantly networking with customers by participating in related conferences and seminars held at home and abroad more than 20 times a year. In addition, it exports to more than 30 overseas countries, including Europe, the United States, the Middle East, and Southeast Asia, and is expanding its activities by entering into strategic partnerships with leading local companies.
An official said, “We want to receive a lot of help for future growth by communicating with medical professionals in various fields and understanding the rapidly changing medical device market trend through KIMES participation so that we can continue the company’s vision and values. He revealed the background of participating in this exhibition.
“In line with the rapidly changing medical device market trend, we are focusing on new product development and approval registration for corporate expansion. Based on our current biodegradable thread processing technology, we are conducting research activities focusing on the development of functional threads.” It is expected to be used in various ways by applying it as a Medical Aesthetic Thread that can maximize the anti-aging effect.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.